Alexander Thompson

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Dongliang Ge, Jacques Fellay, Alexander Thompson et al. · Nature · 2009 · 3.5K citations · Full text

Life Sciences, Genetics, Immunology +13

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski et al. · Gastroenterology · 2010 · 723 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A global scientific strategy to cure hepatitis B

Peter Revill, Francis V. Chisari, Joan M. Block et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 495 citations · Full text

Pharmacy, Biomedical Sciences, Infectious Diseases +14

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14